Dhanalakshmi Thirumalai

Statistics

Publications

Citations

H-Index

Active since

2021

Affiliations

Atara Biotherapeutics (United States)(Current)

Dhanalakshmi Thirumalai is an author at Atara Biotherapeutics (United States) specializing in transplant immunology, immunology, and epstein-barr virus - associated lymphoid neoplasms.

ORCID

Publications per year

2021–2023

Publications

Outcomes for patients with EBV-positive PTLD post-allogeneic HCT after failure of rituximab-containing therapy

Gèrard Socié, Pere Barba, Arie Barlev et al. · Bone Marrow Transplantation · 2023 · 16 citations · Full text

Life Sciences, Immunology, Oncology +12

Clinical Outcomes of Solid Organ Transplant Patients with Epstein-Barr Virus-Driven (EBV +) Post-Transplant Lymphoproliferative Disorder (PTLD) Who Fail Rituximab Plus Chemotherapy: A Multinational, Retrospective Chart Review Study

Vikas R. Dharnidharka, Dhanalakshmi Thirumalai, Ulrich Jaeger et al. · Blood · 2021 · 14 citations

Medicine, Immunology, Pharmacotherapy +17

Treatment Patterns and Unmet Need for Patients with Progressive Multiple Sclerosis in the United States: Survey Results from 2016 to 2021

Crystal Watson, Dhanalakshmi Thirumalai, Arie Barlev et al. · Neurology and Therapy · 2023 · 11 citations · Full text

Medicine, Neurology, Disability Management +16

1–3 of 3